Identification of Ginkgo biloba supplements adulteration using high performance thin layer chromatography and ultra high performance liquid chromatography-diode array detector-quadrupole time of flight-mass spectrometry
- 871 Downloads
Ginkgo biloba is one of the most widely sold herbal supplements and medicines in the world. Its popularity stems from having a positive effect on memory and the circulatory system in clinical studies. As ginkgo popularity increased, non-proprietary extracts were introduced claiming to have a similar phytochemical profile as the clinically tested extracts. The standardized commercial extracts of G. biloba leaf used in ginkgo supplements contain not less than 6 % sesquiterpene lactones and 24 % flavonol glycosides. While sesquiterpene lactones are unique constituents of ginkgo leaf, the flavonol glycosides are found in many other botanical extracts. Being a high value botanical, low quality ginkgo extracts may be subjected to adulteration with flavonoids to meet the requirement of 24 % flavonol glycosides. Chemical analysis by ultra high performance liquid chromatography-mass spectrometry revealed that adulteration of ginkgo leaf extracts in many of these products is common, the naturally flavonol glycoside-rich extract being spiked with pure flavonoids or extracts made from another flavonoid-rich material, such as the fruit/flower of Japanese sophora (Styphnolobium japonicum), which also contains the isoflavone genistein. Recently, genistein has been proposed as an analytical marker for the detection of adulteration of ginkgo extracts with S. japonicum. This study confirms that botanically authenticated G. biloba leaf and extracts made therefrom do not contain genistein, and the presence of which even in trace amounts is suggestive of adulteration. In addition to the mass spectrometric approach, a high performance thin layer chromatography method was developed as a fast and economic method for chemical fingerprint analysis of ginkgo samples.
KeywordsGinkgo biloba L. HPTLC UHPLC-DAD-QToF-MS Dietary supplements Styphnolobium japonicum (L.) Schott
This research is supported in part by “Science Based Authentication of Dietary Supplements” funded by the Food and Drug Administration grant number 1U01FD004246-04, the United States Department of Agriculture, Agricultural Research Service, Specific Cooperative Agreement No. 58-6408-1-603-04. The authors would like to thank Annette Ford for the extraction of samples.
Conflict of interest
The authors declare no conflicts of interest.
- 3.Song J, Fang G, Zhang Y, Deng Q, Wang S (2010) Fingerprint analysis of Ginkgo biloba leaves and related health foods by high-performance liquid chromatography/electrospray ionization-mass spectrometry. J AOAC Int 93:1798–1805Google Scholar
- 8.Demirezer LO, Büyükkaya A, Uçaktürk E, Kuruüzüm-Uz A, Güvenalp Z, Palaska E (2014) Adulteration determining of pharmaceutical forms of Ginkgo biloba extracts from different international manufacturers. Rec Nat Prod 8:394–400Google Scholar
- 11.United States Pharmacopoeia and National Formulary (USP36-NF31) (2013) United States Pharmacopeial Convention, Rockville, MDGoogle Scholar
- 16.United States Pharmacopoeia and National Formulary (USP37-NF32) (2014) United States Pharmacopeial Convention, Rockville, MDGoogle Scholar
- 17.Second Supplement to United States Pharmacopoeia and National Formulary (USP37-NF32) (2014) United States Pharmacopeial Convention, Rockville, MDGoogle Scholar
- 22.Liu JS, Tiu CM, Huang MF (1980) Study on the active constituents of Sophora japonica L. Chin Trad Herb Drugs 11:145–146Google Scholar
- 25.British Pharmacopoeia (2012) British Pharmacopoeia Commission. The Stationary Office, LondonGoogle Scholar